JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleming, S
Right arrow Articles by Griffiths, D F R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleming, S
Right arrow Articles by Griffiths, D F R
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Kidney Cancer
Journal of Clinical Pathology 2005;58:7-14
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


REVIEW

BEST PRACTICE NO 180

Best Practice No 180 Nephrectomy for renal tumour; dissection guide and dataset

S Fleming1, D F R Griffiths2

1 University of Dundee, Ninewells Hospital, Dundee DD1 9SY, UK
2 Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK

Correspondence to:
Professor S Fleming
Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, UK; s.fleming{at}dundee.ac.uk
ABSTRACT
Renal tumours constitute 2.5% of all malignancies and are among the 10 most common malignancies in the UK. Most of these are renal cell carcinomas (RCC) of various subtypes. Although historically RCC has been shown to be resistant to radiotherapy and chemotherapy, recent data suggest that the use of biological treatments, such as adjuvants, may be beneficial in patients with disease that has progressed at the time of presentation. The accurate diagnosis, staging, and grading of RCC is now a crucial element in optimal patient management. There are data to support the importance of histological type, tumour size, stage (especially patterns of extrarenal spread), and grade in determining outcome, and these data have been used to develop the published classification (Heidelberg/Rochester), staging (TNM), and grading (Fuhrman) systems. This article describes a dissection and histological sampling protocol that has been shown to increase the yield of staging information, a guide to histological classification and grading, and finally a minimum dataset for the completion of a satisfactory pathology report.


Keywords: renal cell carcinoma; urothelial carcinoma; nephrectomy; dissection; pathology; dataset




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S J Hayes
Terminal digit preference occurs in pathology reporting irrespective of patient management implication
J. Clin. Pathol., September 1, 2008; 61(9): 1071 - 1072.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E J Soilleux and I S D Roberts
Assessment of the Cardiff nephrectomy cut-up protocol with total blocking of the renal sinus: effect on tumour staging and practical issues.
J. Clin. Pathol., November 1, 2006; 59(11): 1209 - 1211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.